Abridged Bibliography

146 book chapters, 345 articles in scientific journals, 19 books edited

Wyatt RJ, Murphy DL, Belmaker RH, et al (1973).  Reduced monoamine oxidase activity in schizophrenia.  Science 173: 916‑918.

Belmaker RH, et al (1974).  A follow‑up of monozygotic twins discordant for schizophrenia.  Arch Gen Psychiat 30: 219‑222.

Ebstein RP, Belmaker RH, et al (1976).  Lithium inhibition of adrenaline‑sensitive adenylate cyclase.  Nature 259: 411‑413.

Biederman J, Lerner Y and Belmaker RH (1979).  Combination of lithium carbonate and haloperidol in schizoaffective disorder:  a controlled study.  Arch Gen Psychiat.36: 327‑333.

Ebstein RP, Hermoni M and Belmaker RH (1980).  Effect of lithium on cyclic AMP accumulation. J Pharm Exp Ther 213: 161‑167.

Belmaker RH (1981).Receptors, adenylate cyclase, depression and lithium. Biol Psychiat 16: 333‑350. AE Bennett Award

Klein E, Bental E, Lerer B and Belmaker RH (1984).   Carbamazepine and haloperidol versus placebo and haloperidol in excited psychoses:  A controlled study.  Arch Gen Psychiat  41: 165‑170.

Belmaker RH (1984).  Adenylate cyclase and the search for new compounds with the clinical profile of lithium.  Pharmacopsychiatry 17: 9‑15. 1983 Anna Monika Prize

Baron M, Risch N, Hamburger R, Mandel B, Kushner S, Newman M, Drumer D and Belmaker RH (1987). Genetic linkage between X‑chromosome markers and bipolar affective illness. Nature 326: 289‑292.

Avissar S, Schreiber G, Danon A and Belmaker RH (1988). Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 331: 440‑442.

Schreiber G, Avissar S, Danon A and Belmaker RH (1991). Hyperfunctional G proteins in lymphocytes of patients with mania. Biological Psychiatry 29: 273-280.

Kofman O and Belmaker RH (1993).  Biochemical, behavioral and clinical studies of the role of inositol in lithium treatment and depression.  Biological Psychiatry 34: 839-852. (Ziskind-Somerfeld Research Award Paper)

Levine J, Barak Y, Gonsalves M, Szor H, Elizur A, Kofman O and Belmaker RH (1995).  A double-blind controlled trial of inositol treatment of depression.  American Journal of Psychiatry 152: 792-794.

Manji HK, Chen G, Shimon H, Hsiao JK, Potter WZ, Belmaker RH (1995).  Guanine neucleotide-binding in bipolar affective disorder.  Archives of General Psychiatry 52: 135-144.

Benjamin J, Levine J, Fux M, Aviv A, Levy D and Belmaker RH (1995).  Inositol treatment for panic disorder: a double-blind crossover trial.  Amer J of Psychiatry 152: 1084-86.

Ebstein R, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Nemanov L, Katz M, Bennett E and Belmaker RH (1996). D4 receptor polymorphism associated with human personality trait of Novelty Seeking. Nature Genetics 12: 78-80.

Fux M, Levine J, Aviv A, Belmaker RH (1996).  Inositol treatment of obsessive-compulsive disorder. American Journal of Psychiatry 153: 1219-1221.

Shimon H, Agam G, Belmaker RH, Hyde T, Kleinman JE (1997). Reduced frontal cortex inositol levels in post- mortem brain of suicide victims and bipolar patients.  American J Psychiat 154: 1148-50.

Ebstein RP, Belmaker RH (1997).  Saga of an adventure gene: novelty seeking, substance abuse and the dopamine D4 receptor (D4DR) exon III repeat polymorphism.  Molecular Psychiatry 2: 381-384.

Grisaru N, Chudakov B, Yaroslavsky Y, Belmaker RH. (1998)  TMS in mania: a controlled study. Am J Psychiat 155:1608-1610.

Mishory A, Yaroslavsky Y, Bersudsky Y, Belmaker RH. (2000).  Phenytoin as an antimanic anticonvulsant:  a controlled study.  American Journal of Psychiatry 157:463-465

Kozlovsky N, Belmaker RH, Agam G.(2000).  Decreased GSK-3b immunoreactivity in postmortem frontal cortex of schizophrenic patients. American Journal of Psychiatry 57:831-833.

Manji HK, Bowden CL, Belmaker RH (eds).   Mechanism of Antibipolar Treatments.  APA Press,  Washington DC, 2000.

George MS, Belmaker RH (eds).  Transcranial Magnetic Stimulation (TMS) in Neuropsychiatry.  APA Press,  2000.

Agam G, Belmaker RH, Everall I (eds). The Post-Mortem Brain in Psychiatric Research. Kluwer Academic 2002.

Nemets B, Stahal Z, Belmaker RH (2002). Omega-3 fatty acid treatment of depressive breakthrough during unipolar maintenance. American Journal of Psychiatry 159:477-479.

Levine J, Stahl Z, Sela BA, Gavendo S, Ruderman V, Belmaker RH. (2002). Elevated homocysteine levels in young male schizophrenic patients. American Journal of Psychiatry 159:1790-1792.

Arbelle S, Benjamin J, Golin M, Kremer I, Belmaker RH, Ebstein RP (2003). Elevated scores for shyness in grade school children and the serotonin transporter promoter region polymorphism.  American Journal of Psychiatry 160:671-6.

Belmaker RH. (2004). Bipolar Disorder. New England Journal of Medicine, Medical Progress 351:476-486.

Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH (2006). Omega-3 treatment of childhood depression American Journal of Psychiatry 163(6):1098-100

Ben Zion IZ, Tessler R, Cohen L, Lerer E, Bachner-Melman R, Gritsenko I, Nemanov L, Zohar AH, Dina C, Belmaker RH, et al (2006). Polymorphisms in the D4 receptor gene contribute to human sexual behavior Molecular Psychiatry 8;782-786.

George MS, Belmaker RH (eds). Transcranial Magnetic Stimulation in Clinical Psychiatry. APPI Press, Washington DC, 2007.

Belmaker RH (2007). Treatment of bipolar depression (editorial). New England Journal of Medicine 17:1771-1773.

Belmaker RH, Agam G (2008). Major Depressive Disorder. New England Journal of Medicine, 385:47-60.

Agam G, Bersudsky Y, Berry GT, Moechars D, Lavi-Avnon Y, Belmaker RH (2009). Knockout mice in understanding the mechanism of action of lithium.  Biochemical Society Transactions 37:1121-1125.

Lin PY, Mischoulon D, Freeman MP, Matsuok Y, Hibbeln J, Belmaker RH, Su KP (2012). Are omega-3 fatty acids antidepressants or just mood-improving agents?. Mol Psychiatry.17: 1161–1163.

Toker L, Bersudsky Y, Plaschkes I, Chalifa-Caspi V, Berry G, Moechars D, Belmaker RH, Agam G (2014).  Inositol related gene knockouts mimic lithium’s effect on mitochondrial function. Neuropsychopharmacology 39:319-328.